KR840007090A - 3,5-디아라비노시드의 제조방법 - Google Patents

3,5-디아라비노시드의 제조방법 Download PDF

Info

Publication number
KR840007090A
KR840007090A KR1019830005719A KR830005719A KR840007090A KR 840007090 A KR840007090 A KR 840007090A KR 1019830005719 A KR1019830005719 A KR 1019830005719A KR 830005719 A KR830005719 A KR 830005719A KR 840007090 A KR840007090 A KR 840007090A
Authority
KR
South Korea
Prior art keywords
ara
group
monophosphate
dinucleoside
dinucleoside monophosphate
Prior art date
Application number
KR1019830005719A
Other languages
English (en)
Inventor
와이 바라스키트(외 2) 장
Original Assignee
신 뜨라보
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8220274A external-priority patent/FR2537144A1/fr
Application filed by 신 뜨라보 filed Critical 신 뜨라보
Publication of KR840007090A publication Critical patent/KR840007090A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

내용 없음

Description

3,5-디아라비노시드의 제조방법.
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 아라 A는 9-β-D-아라비노푸라노실-아데닌이고, 아라 C는 1-β-D-아라비노푸라노실-시토신이고, P는 모노포스페이트기인 일반식 아라 A-P-아라 C, 아라 C-P-아라 A 및 A-P-아라 A의 디뉴클레오시드 모노포스페이트를 제조하는 방법에 있어서
  2. 1) 3'-위치에 유리 OH기를 갖는 신톤아데닌과 시토신을 제조하고, 2)5'-위치에 유리 OH기를 갖는 신톤아데닌과 시토신을 제조하고, 3)-2관능성인 산화제의 도웃으로 3'-위치에 유리기를 갖는 신톤을 인산화 시키고, -축합제의 도움으로, 얻어진 디에스테르와 선택된 뉴클레오시드를 축합시키고, -얻어진 화합물을 탈보호시켜서 원하는 2량체를 트리에틸아모늄염의 형태로 얻음으로써, 디뉴클레오시드 모노페이트를 합성하는 것을 특징으로 하는 디뉴클레오시드 모노포스페이트의 제조방법.
  3. 제1항에 있어서, 2관능성 인산화제가 0-클로로페닝 포스포로디클로리데이트인 것을 특징으로 하는 디뉴클레오시드 모노포스페이트의 제조방법.
  4. 제2항에 있어서, 축합제가 1-메시틸렌술포닐-3-니트로-1,2,4-트리아졸인 것을 특징으로 하는 디뉴클레오시드 모노포스페이트의 제조방법.
  5. 제1,2 또는 3항에 있어서, -0-클로로페닐기는 4-니트로벤즈알드옥심과 트리에틸아민의 용액으로 탈보호되고, -벤조일기는 암모니아 수용액에 의하여 제거되고, -모노메톡시트리틸기는 아세트산에 의하여 가수분해되는 것을 특징으로 하는 디뉴클레오시드 모노포스페이트의 제조방법.
  6. 아라 A는 9-β-D-아라비노푸라노실-아데닌이고, 아라 C는 1-β-D-아라비노푸라노실-시토신이고, p는 모노포스페이트인 일반식 아라 A-P-아라 C, 알 C-P-아라 A 및 아라 A-P-아라 A의 디뉴클레오시드 모노포페이트에 있어서, 상기 청구범위 제1항 내지 제4항중 어느 하나의 방법에 의하여 제조된 것을 특징으로 하는, 디뉴클레오시드 모노포스페이트.
  7. 제5항에 있어서, 스페이트기의 성분이 0-클로로페닐기인 것을 특징으로 하는, 디뉴클로오시드 모노포스페이트.
  8. 적당한 부형제와 함께 제5항 또는 제6항에서 규정한 디 뉴클레오시드 모노포스페이트를 함유하는 것을 특징으로 하는 약리적 조성물.
  9. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830005719A 1982-12-03 1983-12-02 3,5-디아라비노시드의 제조방법 KR840007090A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8220274 1982-12-03
FR8220274A FR2537144A1 (fr) 1982-12-03 1982-12-03 3',5'-diarabinosides, leur preparation et leur application en therapeutique
FR8304123 1983-03-14
FR8304123A FR2542744B2 (fr) 1982-12-03 1983-03-14 3',5'-diarabinosides, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
KR840007090A true KR840007090A (ko) 1984-12-05

Family

ID=26223174

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830005719A KR840007090A (ko) 1982-12-03 1983-12-02 3,5-디아라비노시드의 제조방법

Country Status (13)

Country Link
EP (1) EP0121635A1 (ko)
JP (1) JPS59112998A (ko)
KR (1) KR840007090A (ko)
AU (1) AU2192783A (ko)
DK (1) DK555683A (ko)
ES (1) ES527737A0 (ko)
FI (1) FI834429A (ko)
FR (1) FR2542744B2 (ko)
GR (1) GR79109B (ko)
IL (1) IL70361A0 (ko)
MA (1) MA19965A1 (ko)
NO (1) NO834433L (ko)
PT (1) PT77767B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
WO1994026273A1 (en) * 1993-05-12 1994-11-24 Hostetler Karl Y Acyclovir derivatives for topical use
US6025335A (en) * 1995-09-21 2000-02-15 Lipitek International, Inc. L-Nucleoside Dimer Compounds and therapeutic uses
GB201317166D0 (en) * 2013-09-27 2013-11-06 Astex Therapeutics Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
DK555683D0 (da) 1983-12-02
FI834429A (fi) 1984-06-04
AU2192783A (en) 1984-06-07
IL70361A0 (en) 1984-03-30
EP0121635A1 (fr) 1984-10-17
PT77767B (fr) 1986-05-30
GR79109B (ko) 1984-10-02
DK555683A (da) 1984-06-04
FI834429A0 (fi) 1983-12-02
FR2542744A2 (fr) 1984-09-21
JPS59112998A (ja) 1984-06-29
FR2542744B2 (fr) 1985-06-14
NO834433L (no) 1984-06-04
ES8406504A1 (es) 1984-08-01
PT77767A (fr) 1984-01-01
ES527737A0 (es) 1984-08-01
MA19965A1 (fr) 1984-07-01

Similar Documents

Publication Publication Date Title
Ralph et al. Studies on Polynucleotides. XI. 1 Chemical Polymerization of Mononucleotides. The Synthesis and Characterization of Deoxyadenosine Polynucleotides2
DE69307506T2 (de) Phosphotriester-typ biologisch-aktiver verbindungen
CA1336820C (en) Fluorinated nucleosides and process for treating retrovirus infections therewith
JP4370164B2 (ja) 新規なウイルス増殖阻害・殺ウイルス方法および新規なピラジンヌクレオチド・ピラジンヌクレオシド類似体
KR840001589A (ko) 1-β-D-아라비노프라노실-(E)-5-(2-할로게노비닐) 우라실-5'-인산염 및 그 제조방법
KR860003256A (ko) 아데노신의 n^6-치환된 데옥시리보스 유사체의 제조방법
Lipkin et al. Action of hydrogen fluoride on nucleotides and other esters of phosphorus (V) acids
DE69108014D1 (de) Verfahren zur herstellung von nucleosiden und ihre analogen.
FR2374334A1 (fr) Nouveaux nucleosides utiles comme medicaments et procede pour leur preparation
CA2083961A1 (en) Synthesis of glycerol di- and triphosphate derivatives
KR900007863A (ko) 향비루스제
KR840007090A (ko) 3,5-디아라비노시드의 제조방법
Fox et al. Nucleosides. LXXIII. Ribosyl analogs of chloramphenicol
ES382365A1 (es) Un metodo de preparacion de citidina-difosfato-colina.
US3787392A (en) Process for the preparation of nucleoside diphosphate esters
US3872083A (en) Nucleoside-5{40 -diphosphate ethanolamines and method of producing the same
KR890017264A (ko) N-포스포노메틸 글리신의 제조방법
Bennett et al. Guanosine tetraphosphate and its analogs. Chemical synthesis of guanosine 3', 5'-dipyrophosphate, deoxyguanosine 3', 5'-dipyrophosphate, guanosine 2', 5'-bis (methylenediphosphonate), and guanosine 3', 5'bis (methylenediphosphonate)
DD140254A1 (de) Verfahren zur herstellung von 4-substituierten pyrimidin-nucleosiden
BERGKVIST et al. The isolation of guanosine-5'-triphosphate from muscle
KR100242357B1 (ko) 비대칭 인산 이에스테르의 제조 방법
US3433783A (en) Method for the production of ribonucleoside-5'-phosphate
SU659573A1 (ru) Спин-меченые производные олигорибонуклеотидов как спиновые зонды дл исследовани механизма действи ферментов и способ их получени
JPS6422823A (en) Antiulcer agent
KR920014823A (ko) β-푸코피라노실 인산염 및 순수 GDP-푸코스의 입체선택적 제조방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid